FRM
ZURA icon

Fox Run Management’s Zura Bio ZURA Stock Holding History

Fox Run Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-46,062
Closed -$262K – 1350
2026
Q1 		$262K Buy
+46,062
New +$278K 0.05% 662

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fox Run Management's ZURA Position: Q2 2026 in Review

Fox Run Management sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 46,062 shares — an estimated $262K sold.

Fox Run Management first reported a position in ZURA in Q1 2026 and held it in 1 quarter. The position peaked at $262K in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Fox Run Management reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 46,062 Zura Bio shares in Q2 2026, an estimated $262K.
  • Fox Run Management first reported a position in Zura Bio in Q1 2026 and held it in 1 quarter.
  • Fox Run Management's Zura Bio position peaked at $262K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.